ATE303153T1 - Ibandroinsäure zur förderung der osseointegration der endoprothesen - Google Patents

Ibandroinsäure zur förderung der osseointegration der endoprothesen

Info

Publication number
ATE303153T1
ATE303153T1 AT99958135T AT99958135T ATE303153T1 AT E303153 T1 ATE303153 T1 AT E303153T1 AT 99958135 T AT99958135 T AT 99958135T AT 99958135 T AT99958135 T AT 99958135T AT E303153 T1 ATE303153 T1 AT E303153T1
Authority
AT
Austria
Prior art keywords
ibandroic
endoprotheses
osseointegration
promote
acid
Prior art date
Application number
AT99958135T
Other languages
English (en)
Inventor
Frieder Bauss
Andreas A Kurth
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of ATE303153T1 publication Critical patent/ATE303153T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
AT99958135T 1998-12-04 1999-11-29 Ibandroinsäure zur förderung der osseointegration der endoprothesen ATE303153T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19855976 1998-12-04
PCT/EP1999/009252 WO2000033849A1 (en) 1998-12-04 1999-11-29 Use of ibandronate for promoting osseointegration of endoprostheses

Publications (1)

Publication Number Publication Date
ATE303153T1 true ATE303153T1 (de) 2005-09-15

Family

ID=7889968

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99958135T ATE303153T1 (de) 1998-12-04 1999-11-29 Ibandroinsäure zur förderung der osseointegration der endoprothesen

Country Status (17)

Country Link
US (1) US6680307B1 (de)
EP (2) EP1614422A3 (de)
JP (1) JP3793023B2 (de)
KR (1) KR100453779B1 (de)
CN (1) CN1173704C (de)
AR (1) AR020017A1 (de)
AT (1) ATE303153T1 (de)
AU (1) AU756540B2 (de)
BR (1) BR9915927A (de)
CA (1) CA2353528C (de)
DE (1) DE69927048T2 (de)
DK (1) DK1135140T3 (de)
ES (1) ES2247842T3 (de)
PT (1) PT1135140E (de)
TR (1) TR200101546T2 (de)
WO (1) WO2000033849A1 (de)
ZA (1) ZA200104140B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004038A1 (en) * 2000-07-12 2002-01-17 Hopital Orthopedique De La Suisse Romande Active biocoating for bone implant
JP2002332235A (ja) * 2001-02-01 2002-11-22 Riderway Corp 骨疾患治療用液体医薬組成物
CA2469779C (en) * 2001-12-21 2008-02-12 The Procter & Gamble Company Method for the treatment of bone disorders
CN1939314A (zh) * 2002-05-10 2007-04-04 弗·哈夫曼-拉罗切有限公司 用于治疗和预防骨质疏松症的二膦酸
SI1596870T2 (sl) * 2002-12-20 2011-07-29 Hoffmann La Roche Formulacija z visokim odmerkom ibandronata
EP1508343B1 (de) * 2003-08-21 2015-11-04 AddBIO AB Bisphosphonat-beschichtete Implantatvorrichtung und Herstellungsverfahren
HUE042316T2 (hu) * 2005-02-01 2019-06-28 Atnahs Pharma Uk Ltd Az Ibandronát A polimorf orvosi alkalmazása
WO2006081962A1 (en) * 2005-02-01 2006-08-10 F.Hoffmann-La Roche Ag Ibandronate polymorph b
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
JPH08505142A (ja) * 1992-12-23 1996-06-04 メルク エンド カンパニー インコーポレーテッド 骨損失を治療及び予防するためのビスホスホネート/エストロゲン療法
US5403829A (en) 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FI92465C (fi) * 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5646134A (en) 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
JPH11511041A (ja) * 1995-06-06 1999-09-28 メルク エンド カンパニー インコーポレーテッド 整形外科的埋め込み装置の無菌性動揺を防止するビスホスホネートセメント組成物
DE69734832T2 (de) * 1996-12-13 2006-08-31 Zymogenetics, Inc., Seattle Zusammensetzungen und verfahren zum stimulieren von knochenwachstum

Also Published As

Publication number Publication date
TR200101546T2 (tr) 2001-11-21
EP1614422A2 (de) 2006-01-11
AR020017A1 (es) 2002-03-27
JP3793023B2 (ja) 2006-07-05
DE69927048D1 (de) 2005-10-06
CA2353528C (en) 2007-04-24
BR9915927A (pt) 2001-08-21
AU1557700A (en) 2000-06-26
EP1614422A3 (de) 2009-02-18
AU756540B2 (en) 2003-01-16
WO2000033849A1 (en) 2000-06-15
CA2353528A1 (en) 2000-06-15
EP1135140B1 (de) 2005-08-31
PT1135140E (pt) 2005-10-31
EP1135140A1 (de) 2001-09-26
CN1329495A (zh) 2002-01-02
US6680307B1 (en) 2004-01-20
CN1173704C (zh) 2004-11-03
KR20010093137A (ko) 2001-10-27
KR100453779B1 (ko) 2004-10-20
ES2247842T3 (es) 2006-03-01
JP2002531509A (ja) 2002-09-24
DK1135140T3 (da) 2005-12-19
ZA200104140B (en) 2002-08-21
DE69927048T2 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
DE60026734D1 (de) Brücke zur can-tcp/ip-verbindung
DE60017336D1 (de) Zusammensetzung zur Herstellung von Harzen
DE69805787D1 (de) Verbindungen zur hemmung der magensäuresekretion
DE69918278D1 (de) Substituierte indolalkansäure
DE60029779D1 (de) Zusammensetzungen zur Herstellung von En-Thiol-Elastomeren
ID27092A (id) Pembuatan ftalat anhidrida
CY2006003I2 (el) Χρηση δαπτομυκινης
DE60042550D1 (de) Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i)
PT945132E (pt) Composicao de ibuprofeno
ATE399350T1 (de) System zur bestimmung der endgültigen position von zähnen
DE69927969D1 (de) Kontrollierte freisetzung von liponsäure
DE19983486T1 (de) Verfahren zur Herstellung von Citalopram
DE69906389D1 (de) Verfahren zur herstellung von citalopram
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
FI970430L (fi) Atsa-asparaziinihappo analogeja 1-beta-interleukiinia muuttavan entsyymin inhibiittoreina
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
DE60019960D1 (de) Herstellung von isobutencopolymere
DE69811330D1 (de) Reinigungspflaster zur verbesserung des hautzustandes
PT1240157E (pt) Derivados substituidos do acido n-benzil-indol-3-il-glioxalico com efeito antitumoral
DE60100858D1 (de) Prozess zur herstellung der kristallinen form i von cabergolin
DE69935509D1 (de) Verfahren zur herstellung von durchscheinenden zahnersätzen
ATE303153T1 (de) Ibandroinsäure zur förderung der osseointegration der endoprothesen
DE69928820D1 (de) Akt zusammensetzungen zur steigerung des überlebens von kardiomyozyten
DE69822711D1 (de) Verfarhen zur Herstellung von Dialkylnaphthalinen
DE69900514D1 (de) Herstellung von Polyalkylsilsesquioxan-Partikeln

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1135140

Country of ref document: EP